E-mail

E-mail a Wiley Online Library Link

Hagop Kantarjian, Francis Giles, Alan List, Roger Lyons, Mikkael A. Sekeres, Sherry Pierce, Robert Deuson and Joseph Leveque The incidence and impact of thrombocytopenia in myelodysplastic syndromes Cancer 109

Version of Record online: 15 MAR 2007 | DOI: 10.1002/cncr.22602

Thrombocytopenia is common in myelodysplastic syndromes (MDS) with an increased prevalence in higher-risk International Prognostic Scoring System categories, and many approved and investigational MDS therapies cause or exacerbate preexisting thrombocytopenia. The incidence of severe bleeding in MDS was higher than reported in current guidelines.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH